JP Stock MarketDetailed Quotes

4527 Rohto Pharmaceutical

Watchlist

2732.0
-42.0-1.51%

20min DelayMarket Closed Dec 13 15:30 JST

645.24BMarket Cap20.21P/E (Static)

Rohto Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Jun 30, 2024

(FY)Mar 31, 2024

(Q4)Mar 31, 2024

(Q3)Dec 31, 2023

(Q2)Sep 30, 2023

(Q1)Jun 30, 2023

(FY)Mar 31, 2023

(Q4)Mar 31, 2023

(Q3)Dec 31, 2022

(Q2)Sep 30, 2022

Total revenue

11.75%68.36B

13.48%270.84B

11.66%69.68B

11.14%73.29B

14.88%66.7B

17.06%61.17B

19.54%238.66B

12.18%62.4B

24.43%65.95B

19.21%58.06B

Cost of revenue

15.28%29.28B

12.16%113.55B

12.86%29.81B

10.52%29.83B

13.25%28.51B

12.09%25.4B

21.28%101.24B

13.93%26.42B

24.51%27B

23.27%25.17B

Gross profit

9.24%39.08B

14.45%157.29B

10.78%39.87B

11.56%43.46B

16.13%38.19B

20.87%35.77B

18.29%137.42B

10.93%35.99B

24.37%38.96B

16.28%32.89B

Operating expense

11.46%27.29B

13.32%117.23B

14.56%35.08B

9.53%29.16B

14.46%28.51B

14.93%24.48B

18.71%103.46B

14.39%30.62B

22.54%26.63B

21.19%24.91B

Staff costs

----

7.52%22.01B

----

11.37%20.47B

----

Selling and administrative expenses

----

16.68%54.22B

----

21.92%46.47B

----

-Selling and marketing expense

----

16.68%54.22B

----

21.92%46.47B

----

Research and development costs

----

21.01%13.39B

----

26.60%11.07B

----

Depreciation and amortization

----

3.59%2.42B

----

10.70%2.34B

----

-Depreciation

----

1.58%1.99B

----

18.12%1.96B

----

-Amortization

----

13.84%436M

----

-16.19%383M

----

Other operating expenses

----

8.98%25.19B

----

16.73%23.12B

----

Operating profit

4.41%11.79B

17.92%40.05B

-10.75%4.79B

15.95%14.3B

21.33%9.67B

36.13%11.29B

17.04%33.96B

-5.41%5.37B

28.51%12.33B

3.20%7.97B

Net non-operating interest income (expenses)

38.52%374M

85.59%1.33B

54.89%412M

150.35%353M

160.71%292M

37.76%270M

495.83%715M

818.92%266M

138.98%141M

100.00%112M

Non-operating interest income

38.92%439M

58.32%1.52B

34.17%428M

100.00%424M

99.44%355M

24.90%316M

161.41%962M

243.01%319M

103.85%212M

83.51%178M

Non-operating interest expense

41.30%65M

-20.65%196M

-69.81%16M

0.00%71M

-4.55%63M

-19.30%46M

-0.40%247M

-59.23%53M

57.78%71M

60.98%66M

Net investment income

12.45%289M

15.19%933M

28.97%463M

3.99%-265M

1.27%478M

0.78%257M

111.49%810M

232.96%359M

-263.31%-276M

9,340.00%472M

Gain(Loss) on financial instruments designated as cash flow hedges

Gain(Loss) on derecognition of available-for-sale financial assets

-187.01%-221M

-274.18%-1.01B

-129.18%-164M

-4,120.00%-603M

53.33%-161M

-122.32%-77M

172.31%577M

345.41%562M

103.23%15M

-56.82%-345M

Income from associates and other participating interests

-98.65%1M

-259.67%-289M

-1,067.57%-358M

-121.25%-17M

-14.29%12M

48.00%74M

26.57%181M

5.71%37M

-54.02%80M

193.33%14M

Special income (charges)

-157.72%-142M

29.91%-246M

2,833.33%246M

-24.49%-1.54B

-63.95%-1.39B

238.93%207M

-715.79%-351M

Less:Other special charges

---23M

----

219.53%153M

--0

----

Less:Write off

167.07%165M

--0

----

24.24%246M

-2,833.33%-246M

-32.34%1.39B

----

-68.47%198M

Other non-operating income (expenses)

-98.89%2M

222.28%505M

56.22%-190M

133.67%263M

-12.50%252M

-64.98%180M

-267.89%-413M

-734.62%-434M

-642.36%-781M

700.00%288M

Income before tax

-1.21%12.09B

21.08%41.52B

3.88%4.95B

19.71%14.03B

26.23%10.3B

26.87%12.24B

23.02%34.29B

11.49%4.76B

22.99%11.72B

6.74%8.16B

Income tax

20.70%3.61B

28.79%10.12B

-50.00%84M

36.45%4.32B

40.74%2.73B

15.58%2.99B

17.56%7.86B

-46.15%168M

-5.55%3.17B

42.47%1.94B

Net income

-8.30%8.48B

18.79%31.39B

5.88%4.86B

13.49%9.71B

21.70%7.57B

31.03%9.25B

24.74%26.43B

15.98%4.59B

38.49%8.55B

-0.99%6.22B

Net income continuous operations

-8.29%8.49B

18.79%31.4B

5.85%4.86B

13.51%9.71B

21.71%7.57B

31.01%9.25B

24.74%26.43B

16.04%4.6B

38.48%8.55B

-1.00%6.22B

Noncontrolling interests

-99.38%1M

778.85%457M

158.62%85M

34.91%143M

209.09%68M

133.33%161M

-13.33%52M

-154.39%-145M

21.84%106M

100.00%22M

Net income attributable to the company

-6.69%8.48B

17.28%30.94B

0.82%4.78B

13.24%9.56B

21.01%7.5B

30.02%9.09B

24.85%26.38B

18.00%4.74B

38.72%8.45B

-1.15%6.2B

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

-6.69%8.48B

17.28%30.94B

0.82%4.78B

13.24%9.56B

21.01%7.5B

30.02%9.09B

24.85%26.38B

18.00%4.74B

38.72%8.45B

-1.15%6.2B

Gross dividend payment

Basic earnings per share

-6.70%37.18

17.29%135.61

0.82%20.95

13.27%41.92

21.01%32.89

30.02%39.85

24.85%115.62

18.00%20.78

38.69%37.01

-1.15%27.18

Diluted earnings per share

-6.67%37.08

17.28%135.21

0.77%20.88

13.25%41.8

21.03%32.8

30.01%39.73

24.85%115.29

18.00%20.72

38.73%36.91

-1.15%27.1

Dividend per share

22.73%27

25.00%15

20.00%12

22.22%22

14.29%12

33.33%10

Currency Unit

JPY

Accounting Standards

NonUS-GAAP

	(Q1)Jun 30, 2024	(FY)Mar 31, 2024	(Q4)Mar 31, 2024	(Q3)Dec 31, 2023	(Q2)Sep 30, 2023	(Q1)Jun 30, 2023	(FY)Mar 31, 2023	(Q4)Mar 31, 2023	(Q3)Dec 31, 2022	(Q2)Sep 30, 2022
Total revenue	11.75%68.36B	13.48%270.84B	11.66%69.68B	11.14%73.29B	14.88%66.7B	17.06%61.17B	19.54%238.66B	12.18%62.4B	24.43%65.95B	19.21%58.06B
Cost of revenue	15.28%29.28B	12.16%113.55B	12.86%29.81B	10.52%29.83B	13.25%28.51B	12.09%25.4B	21.28%101.24B	13.93%26.42B	24.51%27B	23.27%25.17B
Gross profit	9.24%39.08B	14.45%157.29B	10.78%39.87B	11.56%43.46B	16.13%38.19B	20.87%35.77B	18.29%137.42B	10.93%35.99B	24.37%38.96B	16.28%32.89B
Operating expense	11.46%27.29B	13.32%117.23B	14.56%35.08B	9.53%29.16B	14.46%28.51B	14.93%24.48B	18.71%103.46B	14.39%30.62B	22.54%26.63B	21.19%24.91B
Staff costs	----	7.52%22.01B	----	----	----	----	11.37%20.47B	----	----	----
Selling and administrative expenses	----	16.68%54.22B	----	----	----	----	21.92%46.47B	----	----	----
-Selling and marketing expense	----	16.68%54.22B	----	----	----	----	21.92%46.47B	----	----	----
Research and development costs	----	21.01%13.39B	----	----	----	----	26.60%11.07B	----	----	----
Depreciation and amortization	----	3.59%2.42B	----	----	----	----	10.70%2.34B	----	----	----
-Depreciation	----	1.58%1.99B	----	----	----	----	18.12%1.96B	----	----	----
-Amortization	----	13.84%436M	----	----	----	----	-16.19%383M	----	----	----
Other operating expenses	----	8.98%25.19B	----	----	----	----	16.73%23.12B	----	----	----
Operating profit	4.41%11.79B	17.92%40.05B	-10.75%4.79B	15.95%14.3B	21.33%9.67B	36.13%11.29B	17.04%33.96B	-5.41%5.37B	28.51%12.33B	3.20%7.97B
Net non-operating interest income (expenses)	38.52%374M	85.59%1.33B	54.89%412M	150.35%353M	160.71%292M	37.76%270M	495.83%715M	818.92%266M	138.98%141M	100.00%112M
Non-operating interest income	38.92%439M	58.32%1.52B	34.17%428M	100.00%424M	99.44%355M	24.90%316M	161.41%962M	243.01%319M	103.85%212M	83.51%178M
Non-operating interest expense	41.30%65M	-20.65%196M	-69.81%16M	0.00%71M	-4.55%63M	-19.30%46M	-0.40%247M	-59.23%53M	57.78%71M	60.98%66M
Net investment income	12.45%289M	15.19%933M	28.97%463M	3.99%-265M	1.27%478M	0.78%257M	111.49%810M	232.96%359M	-263.31%-276M	9,340.00%472M
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets	-187.01%-221M	-274.18%-1.01B	-129.18%-164M	-4,120.00%-603M	53.33%-161M	-122.32%-77M	172.31%577M	345.41%562M	103.23%15M	-56.82%-345M
Income from associates and other participating interests	-98.65%1M	-259.67%-289M	-1,067.57%-358M	-121.25%-17M	-14.29%12M	48.00%74M	26.57%181M	5.71%37M	-54.02%80M	193.33%14M
Special income (charges)	-157.72%-142M	0	0	0	29.91%-246M	2,833.33%246M	-24.49%-1.54B	-63.95%-1.39B	238.93%207M	-715.79%-351M
Less:Other special charges	---23M	----	----	----	----	----	219.53%153M	--0	--0	----
Less:Write off	167.07%165M	--0	----	----	24.24%246M	-2,833.33%-246M	-32.34%1.39B	----	----	-68.47%198M
Other non-operating income (expenses)	-98.89%2M	222.28%505M	56.22%-190M	133.67%263M	-12.50%252M	-64.98%180M	-267.89%-413M	-734.62%-434M	-642.36%-781M	700.00%288M
Income before tax	-1.21%12.09B	21.08%41.52B	3.88%4.95B	19.71%14.03B	26.23%10.3B	26.87%12.24B	23.02%34.29B	11.49%4.76B	22.99%11.72B	6.74%8.16B
Income tax	20.70%3.61B	28.79%10.12B	-50.00%84M	36.45%4.32B	40.74%2.73B	15.58%2.99B	17.56%7.86B	-46.15%168M	-5.55%3.17B	42.47%1.94B
Net income	-8.30%8.48B	18.79%31.39B	5.88%4.86B	13.49%9.71B	21.70%7.57B	31.03%9.25B	24.74%26.43B	15.98%4.59B	38.49%8.55B	-0.99%6.22B
Net income continuous operations	-8.29%8.49B	18.79%31.4B	5.85%4.86B	13.51%9.71B	21.71%7.57B	31.01%9.25B	24.74%26.43B	16.04%4.6B	38.48%8.55B	-1.00%6.22B
Noncontrolling interests	-99.38%1M	778.85%457M	158.62%85M	34.91%143M	209.09%68M	133.33%161M	-13.33%52M	-154.39%-145M	21.84%106M	100.00%22M
Net income attributable to the company	-6.69%8.48B	17.28%30.94B	0.82%4.78B	13.24%9.56B	21.01%7.5B	30.02%9.09B	24.85%26.38B	18.00%4.74B	38.72%8.45B	-1.15%6.2B
Preferred stock dividends
Other under preferred stock dividend	0	0	0	0	0	0	0	0	0	0
Net income attributable to common stockholders	-6.69%8.48B	17.28%30.94B	0.82%4.78B	13.24%9.56B	21.01%7.5B	30.02%9.09B	24.85%26.38B	18.00%4.74B	38.72%8.45B	-1.15%6.2B
Gross dividend payment
Basic earnings per share	-6.70%37.18	17.29%135.61	0.82%20.95	13.27%41.92	21.01%32.89	30.02%39.85	24.85%115.62	18.00%20.78	38.69%37.01	-1.15%27.18
Diluted earnings per share	-6.67%37.08	17.28%135.21	0.77%20.88	13.25%41.8	21.03%32.8	30.01%39.73	24.85%115.29	18.00%20.72	38.73%36.91	-1.15%27.1
Dividend per share	0	22.73%27	25.00%15	0	20.00%12	0	22.22%22	14.29%12	0	33.33%10
Currency Unit	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY
Accounting Standards	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP

Heat List

Overall

No Data